Clinical trials
Phase 2 Carcinoma, Renal Cell trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
36 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 2 |
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 3 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 2 |
| 2014 | 2 |
| 2016 | 3 |
| 2017 | 2 |
| 2020 | 2 |
| 2021 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 27 |
| Terminated | 4 |
| Recruiting | 2 |
| Active, not recruiting | 1 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University Health Network, Toronto | 5 |
| National Cancer Institute (NCI) | 3 |
| Alliance for Clinical Trials in Oncology | 2 |
| Bristol-Myers Squibb | 2 |
| Merck Sharp & Dohme LLC | 2 |
| Novartis Pharmaceuticals | 2 |
| Sunnybrook Health Sciences Centre | 2 |
| AVEO Pharmaceuticals, Inc. | 1 |
| Abbott | 1 |
| Adherex Technologies, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Renal Cell | 36 |
| Kidney Neoplasms | 7 |
| Neoplasm Metastasis | 4 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Stomach Neoplasms | 2 |
| Adrenocortical Carcinoma | 1 |
| Carcinoma, Hepatocellular | 1 |
| Esophageal Neoplasms | 1 |
| Liver Neoplasms | 1 |
| Neoplasms | 1 |
Trials
Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.